Record Details

CMFRI's natural product from seaweeds to combat fatty liver disease to hit market soon

CMFRI Repository

View Archive Info
 
 
Field Value
 
Relation http://eprints.cmfri.org.in/4462/
https://www.aquaoutlook.com/
 
Title CMFRI's natural product from seaweeds to combat fatty liver disease to hit market soon
 
Creator CMFRI, Library
 
Subject Biochemistry
Seaweed
 
Description CadalminTM LivCure extract, a patent-protected
nutraceutical product developed by the ICARCentral
Marine Fisheries Research Institute (CMFRI)
from seaweeds to combat non-alcoholic fatty liver
disease (NAFLD) will hit the markets soon. CMFRI
signed a Memorandum of Understanding (MoU) with
M/s. Emineotech, a private limited company dealing
with health products, for commercial production and
marketing. Dr. A. Gopalakrishnan, Director of CMFRI
signed a license agreement with Mr. Evanjalist Pathrose,
Managing Director of Emineotech.
 
Publisher Aquaculture Spectrum
 
Date 2022
 
Type Article
NonPeerReviewed
 
Format text
 
Language en
 
Identifier http://eprints.cmfri.org.in/4462/1/Aquaculture%20Spectrum_2022_Natural%20Product.pdf
CMFRI, Library (2022) CMFRI's natural product from seaweeds to combat fatty liver disease to hit market soon. Aquaculture Spectrum, 5 (12). p. 66. ISSN 2581-7892